KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
603567 HeiLongJiang ZBD Pharmaceutical
- 11.96
- -0.22-1.81%
Market Closed Dec 13 15:00 CST
11.26BMarket Cap17.23P/E (TTM)
12.22High11.95Low138.17KlotVolume12.15Open12.18Pre Close167.18MTurnover1.47%Turnover Ratio23.82P/E (Static)941.14MShares13.6352wk High1.45P/B11.24BFloat Cap8.6952wk Low13.40Limit Up939.54MShs Float58.82Historical High10.96Limit Down2.22%Amplitude8.69Historical Low0.20Dividend TTM12.10Avg Price91.84KlotAsk1.67%Div YieldTTM100Lot Size43.72KlotBid
HeiLongJiang ZBD Pharmaceutical News
Legal Opinion of Beijing Lantai Law Firm on the Repurchase and Cancellation of Some Restricted Shares of the 2023 Restricted Stock Incentive Plan by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Implementation Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the Repurchase and Cancellation of Some Restricted Shares of the 2023 Restricted Stock Incentive Plan
Treasure Island: Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the extension of the controlling shareholder\'s partial share pledge
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the extension of the controlling shareholder\'s partial share pledge
Announcement Regarding Partial Shareholdings of Heilongjiang ZBD Pharmaceutical Co., Ltd. being Released from Pledge and Re-pledged by Controlling Shareholders.
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s 2023 Annual Equity Distribution Implementation Announcement.
Legal Opinion of Lantai Law Firm, Beijing regarding the repurchase and cancellation of some restricted stocks of Heilongjiang ZBD Pharmaceutical Co., Ltd. under the restricted stock incentive plan in 2023.
Announcement from Heilongjiang ZBD Pharmaceutical Co., Ltd. regarding the repurchase and cancellation of some restricted stocks of the restricted stock incentive plan in 2023.
Announcement to creditors regarding repurchase and cancellation of restricted stocks by Heilongjiang ZBD Pharmaceutical Co., Ltd.
Announcement on the implementation of partial restricted share buyback cancellation by Heilongjiang ZBD Pharmaceutical Co., Ltd.
Legal opinion of Lantai Law Firm of Beijing on the implementation of the cancellation of restricted stock repurchase of Heilongjiang ZBD Pharmaceutical Co., Ltd.'s 2023 restricted stock incentive plan.
Announcement of the 2023 profit distribution plan of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the company's repurchase and cancellation of restricted stocks for which some incentives have been granted but sales restrictions have not yet been lifted
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the repurchase and cancellation of some restricted shares to creditors
An indicative announcement by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on changes in the equity of shareholders holding 5% or more of the shares by more than 1%
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the completion of the processing of non-public issuance of exchangeable corporate bonds by the controlling shareholder to supplement pledge shares
An indicative announcement by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the controlling shareholder\'s intention to apply for supplementary pledges of shares in non-public exchangeable corporate bonds
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the pledge of some shares of the controlling shareholder and the release of the pledge
An indicative announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on changes in equity of shareholders holding 5% or more of the shares by more than 1%
Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.\'s supplementary and corrective announcement on the replacement of funds raised by non-public shares and pre-investment of self-financing funds
